Patients with chronic kidney disease (CKD) exhibit tremendously elevated risk for
cardiovascular disease, particularly ischemic heart disease, due to premature vascular and …

Abstract Rationale & Objective Vitamin D is widely used to manage chronic kidney disease-
mineral and bone disorder (CKD-MBD). We aimed to evaluate the effects of vitamin D …

BACKGROUND: The American Heart Association (AHA), in conjunction with the National
Institutes of Health, annually reports the most up-to-date statistics related to heart disease …

Cardiovascular disease (CVD) is the leading cause of death in patients with chronic kidney
disease (CKD). Multiple factors account for the increased incidence of cardiovascular …

Chronic kidney disease (CKD) is commonly associated with vitamin K deficiency. Some of
the serious complications of CKD are represented by cardiovascular disease (CVD) and …

Abstract Two decades ago, Kidney Disease: Improving Global Outcomes coined the term
chronic kidney disease–mineral and bone disorder (CKD–MBD) to describe the syndrome of …

Background Vascular calcification (VC) is a common comorbidity among patients with
chronic kidney disease (CKD), indicating major cardiovascular events. This study aimed to …

Background Kidney reabsorption plays a vital role in magnesium homeostasis. This study
aimed to determine the relationship between the kidney reabsorption-related magnesium …

Introduction Vascular calcification (VC) which is the pathological mineral deposition in the
vascular system, predominantly at the intimal and medial layer of the vessel wall, is an …

The age-old axiom that one is as old as his or her vessels are, calls for ongoing critical re-
examination of modifiable risk factors of accelerated vascular ageing in chronic kidney …